JMDC (4483.T) Osake Kurssi
JMDC Kurssi
Viimeisten 8 vuoden aikana JMDCn liikevaihto kasvoi 42,1 % vuodessa ja ylsi 49,82 Mrd. JPY:een. Osakekohtainen tulos on kasvanut 37,1 % vuodessa viimeisten 8 vuoden aikana. JMDCn nettomarginaali 13,6 % on laskenut verrattuna 14,9 %:iin muutama vuosi sitten. Nykyhinnalla osinkotuotto on noin 0,93 %. Jakosuhde on noin 21 % tuloksesta. Osinko on kasvanut 35,8 % vuodessa viimeisten 4 vuoden aikana. JMDCn 12 kuukauden konsensustavoitehinta on 5 508,00 JPY, noin yli kurssia 50,5 %. 18 analyytikosta 17 suosittaa ostoa — kokonaiskonsensus on Osta.
JMDC osakekurssi
JMDC liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset JMDC -osakkeesta
JMDC Inc is a leading company with a unique business model. They specialize in offering comprehensive health data analysis and consulting services. Their innovative solutions enable healthcare professionals to make informed decisions and improve patient outcomes. By leveraging cutting-edge technology and partnering with industry experts, JMDC Inc is able to provide valuable insights and support to healthcare organizations. With a strong focus on data-driven solutions and continuous innovation, JMDC Inc strives to drive positive changes in the healthcare sector. Overall, JMDC Inc's business model revolves around delivering impactful healthcare data analysis and consulting services to empower the industry.
JMDC Inc is primarily active in the healthcare and data analysis industries.
The main competitors of JMDC Inc in the market are [insert names of competitors]. These companies operate in the same industry as JMDC Inc and offer similar products and services. As a professional stock website, we provide comprehensive information on JMDC Inc's competitors, financial performance, and market analysis. Stay informed about the competitive landscape and make well-informed investment decisions.
JMDC Inc is a leading company in the healthcare industry. It was founded in Japan in [year] and has since established a strong reputation for its data analysis and consulting services. With a focus on healthcare-related information, JMDC Inc offers valuable insights to various stakeholders within the industry, including medical institutions and pharmaceutical companies. The company has a rich history of delivering innovative solutions to improve healthcare outcomes and optimize operational efficiency. JMDC Inc's commitment to excellence and its continual growth make it a trusted partner in the healthcare sector.
Some significant milestones achieved by JMDC Inc include expanding its market presence, achieving consistent revenue growth, and introducing innovative healthcare solutions. JMDC Inc has successfully forged strategic partnerships with prominent healthcare providers, resulting in increased market share and improved accessibility to its services. With a strong commitment to delivering high-quality data analytics and software solutions, JMDC Inc has consistently witnessed revenue growth year after year. Furthermore, the company has been at the forefront of developing cutting-edge healthcare technologies, optimizing patient care, and enhancing overall healthcare efficiency. JMDC Inc continues to strive for excellence by embracing innovative solutions and expanding its reach in the healthcare industry.
JMDC Inc is primarily present in Japan.
JMDC Inc represents strong values and a clear corporate philosophy. With a focus on providing comprehensive healthcare information services, JMDC Inc aims to contribute to the improvement of medical care in Japan. The company is committed to promoting transparency, accessibility, and efficiency in the healthcare industry through their innovative solutions. By leveraging advanced technology and data analysis, JMDC Inc strives to enhance medical decision-making processes and drive positive patient outcomes. Their dedication to integrity, professionalism, and continuous growth underpin their commitment to delivering high-quality healthcare solutions. JMDC Inc's values and corporate philosophy are deeply rooted in their mission to create a healthier and more sustainable society.
Analyytikot asettavat tällä hetkellä JMDC-osakkeelle keskimääräisen tavoitehinnan 5 503,75 JPY (mediaani: 5 508,00 JPY), mikä merkitsee +50,4 % viimeisimpään hintaan verrattuna. Konsensus perustuu 18 analyytikkoarvioon.
18 analyytikkoa arvioi tällä hetkellä JMDC-osaketta: 17 suosittaa ostoa, 1 pitoa ja 0 myyntiä.
Nykyisellä valuuttakurssilla JMDC-osake noteerataan hintaan 20,68 EUR (3 660,00 JPY).
JMDC-osake (4483.T) on listattuna 3 pörssissä, muun muassa: Tokio (JPX) (4483.T), Frankfurt (6JM.F), München (6JM.MU).
JMDC Inc is a Japanese company that specializes in providing medical services and products. The company was founded in 1987 and has since expanded its business into various areas. Its main business fields include data analysis, health management, and medical products. JMDC Inc collects medical data and uses it to gain insights into diseases and treatment options. These insights are then used to develop new medical products and improve existing ones. The company also offers solutions for corporate health promotion, such as disease prevention programs, support for lifestyle changes, and promoting a healthy work environment. In addition, JMDC Inc offers a variety of medical products, including blood pressure measurement devices, diabetes monitoring devices, and allergy detection devices. Another product is the "Smart Seat," a sensor system that aims to improve people's sitting position and reduce back pain. A key part of JMDC Inc's business model is its joint venture with Aetna Japan, a leading provider of health insurance in Japan. This partnership allows JMDC Inc to expand its capabilities in health management and develop new products and services in close collaboration with Aetna Japan. Overall, JMDC Inc's business model focuses on gaining insights into diseases through data analysis and health management, and incorporating these insights into the development of new medical products and services. The company strives to play a leading role in promoting health and well-being in Japan and beyond.
liikevaihto JMDC on 49,82 Mrd. JPY. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
voitto JMDC on 6,77 Mrd. JPY. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
JMDC:n hinta-voitto-suhde (P/E) on tällä hetkellä 35,70. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan JMDC-osakkeen arvostusta.
JMDC:n hinta-myynti-suhde (P/S) on tällä hetkellä 4,85. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii JMDC-osakkeen arvostuskennuslukuna.
JMDC:n Eulpool-laatuscore on 5/10.
JMDC:n ISIN on JP3386690006. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
JMDC:n WKN on A2PWQC. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
JMDC:n ticker on 4483.T. Tämä pörssinoteeraus käytetään JMDC-osakkeiden kauppaan pörssissä.
JMDC osake
JMDC vertaisryhmä
JMDC Ticker
JMDC FIGI
Kaikki tunnusluvut ja syvällinen analyysi JMDC:sta
Meidän osakeanalyysimme JMDC-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut JMDC:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: